JMJD6 and ovarian carcinoma: The inhibition of JMJD6 enzymatic activity by WL12 lead to decreased cell proliferation.421 Another JMJD6 inhibitor, SKLB325, significantly suppressed the proliferation and induced cell apoptosis of ovarian cancer in a dose-dependent manner.